GSK.L vs. ASWC.DE
GSK.L (GlaxoSmithKline plc) is a stock, while ASWC.DE (HANetf Future of Defence UCITS ETF Acc EUR) is Aerospace & Defense fund tracking the EQM Future of Defence Index. Over the past year, GSK.L returned 32.87% vs 20.82% for ASWC.DE. At a 0.03 correlation, their price movements are largely independent.
Performance
GSK.L vs. ASWC.DE - Performance Comparison
Loading charts...
Different Trading Currencies
GSK.L is traded in GBp, while ASWC.DE is traded in EUR. To make them comparable, the ASWC.DE values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, GSK.L achieves a 10.61% return, which is significantly lower than ASWC.DE's 12.10% return.
GSK.L
- 1D
- 1.10%
- 1M
- 6.15%
- YTD
- 10.61%
- 6M
- 10.61%
- 1Y
- 32.87%
- 3Y*
- 17.81%
- 5Y*
- 6.60%
- 10Y*
- 6.03%
ASWC.DE
- 1D
- -0.72%
- 1M
- 7.57%
- YTD
- 12.10%
- 6M
- 12.20%
- 1Y
- 20.82%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GSK.L vs. ASWC.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
GSK.L GlaxoSmithKline plc | 10.61% | 41.46% | -3.51% | 6.74% |
ASWC.DE HANetf Future of Defence UCITS ETF Acc EUR | 12.10% | 45.49% | 33.28% | 15.87% |
Correlation
The correlation between GSK.L and ASWC.DE is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.09 |
Correlation (All Time) Calculated using the full available price history since Jul 4, 2023 | 0.03 |
The correlation between GSK.L and ASWC.DE shifts across timeframes, from -0.09 (1 year) to 0.03 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GSK.L vs. ASWC.DE — Risk / Return Rank
GSK.L
ASWC.DE
GSK.L vs. ASWC.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK.L) and HANetf Future of Defence UCITS ETF Acc EUR (ASWC.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GSK.L | ASWC.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.30 | ||
| Sortino ratioReturn per unit of downside risk | +0.55 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.18 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 1.78 | 1.74 | +0.05 |
| Martin ratioReturn relative to average drawdown | 4.57 | 3.82 | +0.74 |
Loading charts...
Drawdowns
GSK.L vs. ASWC.DE - Drawdown Comparison
The maximum GSK.L drawdown since its inception was -42.39%, which is greater than ASWC.DE's maximum drawdown of -11.61%. Use the drawdown chart below to compare losses from any high point for GSK.L and ASWC.DE.
Loading charts...
Drawdown Indicators
| GSK.L | ASWC.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.39% | -11.61% | -30.78% |
Max Drawdown (1Y)Largest decline over 1 year | -18.35% | -11.61% | -6.74% |
Max Drawdown (3Y)Largest decline over 3 years | -27.42% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -42.39% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -42.39% | — | — |
Current DrawdownCurrent decline from peak | -11.02% | -2.76% | -8.26% |
Average DrawdownAverage peak-to-trough decline | -12.78% | -2.37% | -10.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.93% | 5.28% | +1.65% |
Volatility
GSK.L vs. ASWC.DE - Volatility Comparison
GlaxoSmithKline plc (GSK.L) and HANetf Future of Defence UCITS ETF Acc EUR (ASWC.DE) have volatilities of 6.10% and 5.91%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GSK.L | ASWC.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 5.91% | +0.19% |
Volatility (6M)Calculated over the trailing 6-month period | 18.09% | 15.42% | +2.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.04% | 19.97% | +5.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.68% | 18.65% | +5.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.09% | 18.65% | +3.44% |
Dividends
GSK.L vs. ASWC.DE - Dividend Comparison
GSK.L's dividend yield for the trailing twelve months is around 3.38%, while ASWC.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASWC.DE HANetf Future of Defence UCITS ETF Acc EUR | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GSK.L GlaxoSmithKline plc | 3.38% | 3.51% | 4.53% | 3.84% | 5.30% | 4.93% | 5.90% | 4.45% | 5.31% | 5.99% | 4.88% | 5.77% |
Frequently Asked Questions
GSK.L and ASWC.DE have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GSK.L and ASWC.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer